Operating Lease, Right-of-Use Asset of 89bio, Inc. from 30 Jun 2022 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
89bio, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Jun 2022 to 30 Jun 2025.
  • 89bio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2025 was $1,256,000, a 35% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

89bio, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $1,256,000 -$686,000 -35% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $1,409,000 -$709,000 -33% 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q4 2024 $1,572,000 -$721,000 -31% 31 Dec 2024 10-Q 08 Aug 2025 2025 Q2
Q3 2024 $1,760,000 +$1,522,000 +639% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $1,942,000 +$1,662,000 +594% 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 $2,118,000 +$1,796,000 +558% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $2,293,000 +$1,930,000 +532% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $238,000 -$165,000 -41% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $280,000 +$171,000 +157% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $322,000 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $363,000 31 Dec 2022 10-K 01 Mar 2024 2023 FY
Q3 2022 $403,000 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $109,000 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.